These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1083216)

  • 21. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left-handed "Z" DNA antibodies in rheumatoid arthritis and systemic lupus erythematosus.
    Sibley JT; Lee JS; Decoteau WE
    J Rheumatol; 1984 Oct; 11(5):633-7. PubMed ID: 6334742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis.
    Kacaki JN; Callerame ML; Blomgren SE; Vaughan JH
    Arthritis Rheum; 1971; 14(2):276-82. PubMed ID: 4927485
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassay.
    Valle RR; Eaton RB; Schnneider G; Schur PH
    Clin Immunol Immunopathol; 1985 Mar; 34(3):345-54. PubMed ID: 3882289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between anti-DNA antibody titre and psychiatric manifestations in systemic lupus erythematosus.
    Levo Y; Kalaci J; Pick AI; Golomb M
    Postgrad Med J; 1976 Dec; 52(614):795-8. PubMed ID: 1087726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic methods in the differential diagnosis of collagen diseases].
    Kalden JR
    Med Welt; 1975 Dec; 26(50):2242-7. PubMed ID: 765672
    [No Abstract]   [Full Text] [Related]  

  • 29. A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus.
    Pisetsky DS; Grudier JP; Gilkeson GS
    Arthritis Rheum; 1990 Feb; 33(2):153-9. PubMed ID: 2407246
    [No Abstract]   [Full Text] [Related]  

  • 30. [Better characterization of antinuclear factors (proceedings)].
    Stojan B
    Z Rheumatol; 1976; 35 Suppl 4():suppl 427-32. PubMed ID: 790835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of lupus biology in rheumatoid polyarthritis].
    Bardin T
    Ann Med Interne (Paris); 1984; 135(6):411-3. PubMed ID: 6334464
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus.
    Cossio PM; Arana RM; Morteo OG; Hübscher O; Roux EB
    Ann Rheum Dis; 1971 Nov; 30(6):640-4. PubMed ID: 5316115
    [No Abstract]   [Full Text] [Related]  

  • 34. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical significance of serum sialic acid in rheumatoid arthritis and systemic lupus erythematosus].
    Ota T; Uemura A; Eto S; Suzuki H
    J UOEH; 1985 Dec; 7(4):401-7. PubMed ID: 3878988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Webb J; Whaley K; Lee P
    Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical significance of antibodies to native DNA as measured by a DNA binding technique in patients with articular features of rheumatoid arthritis.
    Grennan DM; Sloane D; Behan A; Dick WC
    Ann Rheum Dis; 1977 Feb; 36(1):30-3. PubMed ID: 300231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody.
    Benson MD; Cohen AS
    Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.